-Journal Listings Increase by 26% and Generate Content Driven Revenue-
BETHESDA, Md.–(BUSINESS WIRE)–Healthnostics, Inc., a medical and biotechnology analytics information and technology company, today announced that the MedBioWorld medical and biotechnology journal database has been expanded by 26% to over 16,000 listings, including the recent addition of the Journal Citation Reports™ ranking of the world’s leading journals. In conjunction with this expansion, MedBioWorld has initiated a new affiliate program that has attracted partners who have already begun to generate revenue for Healthnostics.
“We believe that we have now built the largest and highest quality medical and biotechnology journals database in the world. Our new affiliate partners were attracted to us because of our high quality site and user traffic, and we are pleased with the new revenue stream and prospects they bring to Healthnostics,” stated Alan Grofé, President.
About Healthnostics
Healthnostics, Inc. is a medical and biotechnology analytics company that provides patient clinical monitoring and risk management systems to acute care hospitals, and utilizes its Internet portals to deliver medical and biotechnology resource information to industry professionals as well as to the general public. Healthnostics’ major products include: MedGuardian, a patient care monitoring and risk management system for hospitals that is fully Web-based; and through the MedBioWeb subsidiary, MedBioWorld(tm), one of the largest professional medical and biotechnology resource and reference portal sites on the Internet, MedNets.com healthcare professional and consumer portal, and FamilyMedicalNet, a consumer healthcare information portal.
For further information regarding Healthnostics, please visit Healthnostics (www.healthnostics.com), MedGuardian (www.med-guardian.com), MedBioWorld (www.medbioworld.com), FamilyMedicalNet (www.familymedicalnet.com) and MedNets (www.mednets.com).
This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management’s current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.
Contact:
for Healthnostics, Inc.
Cynthia DeMonte, 917-273-1717
cynthiademonte@gmail.com
Source: Healthnostics, Inc.